CRO / CMO / CDMO

Delve into the world of CRO / CMO / CDMO in China’s pharmaceutical industry. Fineline Info & Tech provides reliable data, news, and insights on CRO / CMO / CDMO to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

MOFCOM and MOST Open Consultation on Revised Technology Export Catalogue – 40 Technologies Across AI, Biopharmaceuticals and Photovoltaics Proposed for Addition
Policy / Regulatory

MOFCOM and MOST Open Consultation on Revised Technology Export Catalogue – 40 Technologies Across AI, Biopharmaceuticals and Photovoltaics Proposed for Addition

China's Ministry of Commerce (MOFCOM) and the Ministry of Science and Technology (MOST) jointly launched a public consultation on proposed revisions to the Catalogue of Technologies Prohibited or Restricted from…

Brii Biosciences Launches BRiSC Bispecific siRNA Platform – Dual‑Target RNAi Engine to Advance Next‑Generation RNA Therapeutics in Prevalent Diseases

Brii Biosciences Launches BRiSC Bispecific siRNA Platform – Dual‑Target RNAi Engine to Advance Next‑Generation RNA Therapeutics in Prevalent Diseases

AbbVie's RINVOQ Wins NMPA Approval for Severe Alopecia Areata – Ninth Indication in China Three Months After EU Clearance

AbbVie’s RINVOQ Wins NMPA Approval for Severe Alopecia Areata – Ninth Indication in China Three Months After EU Clearance

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Tigermed Completes Share Transfer of Teddy Clinical Laboratory to Frontage Laboratories for RMB 270 Million
CompanyDeals

Tigermed Completes Share Transfer of Teddy Clinical Laboratory to Frontage Laboratories for RMB 270 Million

Shanghai MicuRx and GenScript’s ProBio Unit Sign Strategic Deal to Accelerate Antibody‑Drug Conjugate (ADC) Development
CompanyDeals

Shanghai MicuRx and GenScript’s ProBio Unit Sign Strategic Deal to Accelerate Antibody‑Drug Conjugate (ADC) Development

China’s Insilico, Mabwell, and Chemexpress Forge AI‑Driven ADC Collaboration
CompanyDeals

China’s Insilico, Mabwell, and Chemexpress Forge AI‑Driven ADC Collaboration

Biocytogen Eyes A‑Share Listing on Shanghai’s STAR Market to Fund Preclinical R&D Growth
CompanyDeals

Biocytogen Eyes A‑Share Listing on Shanghai’s STAR Market to Fund Preclinical R&D Growth

ChemPartner & Hayoo Forge Nucleic‑Acid Delivery Partnership to Expand Extranodal Therapies
CompanyDeals

ChemPartner & Hayoo Forge Nucleic‑Acid Delivery Partnership to Expand Extranodal Therapies

PackGene & CMRI Announce AAV Screening Kit for Global Gene Therapy R&D
CompanyDeals

PackGene & CMRI Announce AAV Screening Kit for Global Gene Therapy R&D

WuXi Biologics Reports 16.1% Revenue Growth in H1 2025, Launches WuXiHigh 2.0 Platform
Company

WuXi Biologics Reports 16.1% Revenue Growth in H1 2025, Launches WuXiHigh 2.0 Platform

CANbridge Pharmaceuticals Secures HK 100 Million Equity Financing From Baheal Pharma
CompanyDeals

CANbridge Pharmaceuticals Secures HK 100 Million Equity Financing From Baheal Pharma

Show More